Equillium, Inc.EQEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Equillium, Inc. is a clinical-stage biotechnology company focused on developing novel therapies for severe autoimmune and inflammatory diseases with high unmet medical needs. It advances pipeline candidates targeting immune system dysregulation, primarily catering to patients and healthcare providers across the United States.